Date post: | 24-Oct-2014 |
Category: |
Documents |
Upload: | aqifawaris |
View: | 81 times |
Download: | 7 times |
Acknowledgements
This is the official report of Jawa Pharmaceuticals (pvt) limited. We hope it will soon be
very helpful for you. Our sincere thanks to professor Ghulam Ahmed Rana for giving us a
chance to work in a group where we were able to polish our communication, presentation
and all kind of creative skills. Special thanks to Agha Asghar for providing references and
Muhammad BaqirJawa (Managing director of Pharmaceuticals) without them we could not
have been visit factory where most of our research was completed and many of our surveys
were conducted.
We would like to thank our parents and family members as well because they provided us
the financial and moral support in doing this project. And last of all whatever we have done,
it is just because of the coordination and cooperation of all the members of the group. All
had worked hard for collecting the data and performing surveys.
Table of ContentsINTRODUCTION......................................................................................................................................................... 8
BRIEF HISTORY.......................................................................................................................................................... 9
SITUATIONAL ANALYSIS.....................................................................................................................................12
STRUCTURE OF THE ORGANIZATION...........................................................................................................13
ORGANIZATION STRUCTER.......................................................................................................................... 14
LOCATION:................................................................................................................................................................. 15
1 | P a g e
KEY PLAYERS............................................................................................................................................................ 16
Number of total employee.................................................................................................................................. 16
MISSION STATEMENT.......................................................................................................................................... 17
Vision............................................................................................................................................................................ 17
GOALS AND OBJECTIVES..................................................................................................................................... 18
O B J E C T I V E S ................................................................................................................................................. 18
EXTERNAL AND INTERNAL ASSESMENT....................................................................................................19
EFE Matrix.................................................................................................................................................................. 23
IFE Matrix................................................................................................................................................................... 24
CPM............................................................................................................................................................................... 25
SWOT MATRIX......................................................................................................................................................... 26
Space Matrix for Millat tractor..........................................................................................................................27
BCG MATRIX.............................................................................................................................................................. 29
IE Matrix...................................................................................................................................................................... 30
GRAND STRATEGY:................................................................................................................................................ 31
Core Competencies and Key Success Factors:............................................................................................32
CORPORATE CULTURE.........................................................................................................................................33
Strategies undertaken at the:............................................................................................................................ 35
HR Department of Millat Tractors...................................................................................................................36
Main functions of HR department in Millat Tractors Limited........................................................37
Performance Evaluation:..................................................................................................................................... 38
Labour laws of Islamic Republic of Pakistan and those practiced in Millat Tractors Limited......................................................................................................................................................................................... 38
Labour Rights in the Constitution...........................................................................................................38
Termination of the Contract.......................................................................................................................... 39
Paid Leave and Other Leave Entitlements:.........................................................................................40
Equality:.................................................................................................................................................................. 41
Freedom of association:.............................................................................................................................. 42
Registration of unions:................................................................................................................................ 42
ADMINSITRATION STRATEGIES......................................................................................................................44
DECISION MAKING................................................................................................................................................. 44
TOTAL QUALITY MANAGEMENT.................................................................................................................... 45
Compensation and Benefits:.............................................................................................................................. 46
Workers Concession Shop:................................................................................................................................. 47
Workers concession shop where flour, ghee, sugar, soap, etc is provided only to the workers at subsidized rate................................................................................................................................. 47
2 | P a g e
Market Analysis....................................................................................................................................................... 48
Segments and Target Market........................................................................................................................ 48
Products:................................................................................................................................................................ 48
Price:........................................................................................................................................................................ 51
Placement:............................................................................................................................................................. 51
Promotions:........................................................................................................................................................... 53
Political:.................................................................................................................................................................. 53
Market Share:............................................................................................................................................................ 54
Market Position........................................................................................................................................................ 55
USP................................................................................................................................................................................. 57
USP of Millat Tractors Limited:.................................................................................................................... 57
Competitive Analysis:............................................................................................................................................58
FINANCIAL STRATEGISE.....................................................................................................................................59
OTHER STRATEGIES..............................................................................................................................................61
Research and Development........................................................................................................................... 61
Production:............................................................................................................................................................ 63
CONTROL PROCEDURES..................................................................................................................................... 64
Marketing control...............................................................................................................................................64
PRODUCTIN CONTROL.................................................................................................................................... 65
QUALITY CONTROL........................................................................................................................................... 66
FINANCE CONTROL:......................................................................................................................................... 66
HRM CONTROL:................................................................................................................................................... 67
PROBLEM SECTION............................................................................................................................................... 69
3 | P a g e
COMPANY PROFILE
Name : Jawa Pharmaceutical
Logo :
Established in : 1967
Industry : Pharmaceuticals Industry
Business Based : Private Company
Type of Ownership : Corporation.
Location : 112/10 Quaid-e-Azam industrial area, KotLakhpat,
Lahore, Pakistan
Brief history
Ambition to get success is a driving force for any noble aim. No ambition can germinate
without seed of commitment and light of consistent effort. By grace of God, the immense
4 | P a g e
contribution of Jawa Pharmaceuticals towards the health care of the masses is an
unprecedented glittering mark of strenuous effort and consolidated strategies.
Jawa Pharmaceuticals was established with the objective of developing medicines to
cure suffering humanity. Its main concern was to earn idea-breeding minds by grasping the
finger of progress in the field of science and research.
For the first time, company was licensed in 1967 when it was located in Samanabad
then with the passage of time; we felt the need of extension, so the company was shifted to
Garden Town in 1972, then finally to KotLakphat in 1982.
As Jawa Pharmaceuticals has always been typing to stare in the eyes of time
challenges.
Therefore, in 2005, by visualizing our continuous commitment with quality, we got
accreditation of ISO 9001-2000. This reveals we have a solid control on our processes and
drugs. The company is well aware of the international standard and its demand. Due to
diversified planning and concrete action, all departments are well equipped with state of
art machinery and modern functioning. System, especially the quality department stands a
few inches above others regarding technology and expertise.
Organizational Hierarchy
5 | P a g e
Location of office
JawaPharmaceuticals (pvt) Ltd.
112/10 Quaid-e-Azam industrial area, KotLakhpat, Lahore, Pakistan
6 | P a g e
C.E.O
Management Director
Marketing
Department
Marketing NSM
Export
Manager
Procurement
Manager
HR Manag
er
Assistant
Finance Department
M.I.S
Production Director
Plant Manager
Nature of business
It is a Private limited company.
Total no of employees:
Jawa pharmaceutical have approx. 280 employees which includes management authorities,
department heads, Supervisors, Assistants and all the functional level employees
Key players:
Mission & Vision statement
7 | P a g e
Jawa Pharmaceuticals (pvt) Limited.
Raza Jawa
Baqir Ali jawa
Sajid Ali jawa
Vision Statement
“Commitment to save humanity”
Mission Statement
“Committed to manufacture quality products to satisfy our customers by
efficient utilization and development of all our resources”
Suggested Mission Statement
“Committed to manufacture quality products to ensure the health of our
customer around the world by effective utilization and development of
all our human and technological resources”
Goal & objective;
Objectives:
8 | P a g e
To achieving its exporting goal Jawa pharmaceuticals would be providing its
products to Sri-lanka, Philippine.
Provide corporate sales growth with a sufficient rate annually with a significant
increase in per-person productivity level without compromising profitability.
Organization development its own online portal to attain efficiency.
Introduction of more products in diversified range includes
Dermatological products
Cephalosporins.
Quinolones and macrolides to attain more classes of customers.
Goals:
Expanding business through enhancing product lane.
Jawa pharmaceuticals will enhance its business through market development
strategy (Exporting).
Improvement in Financial planning & efficiency of others systems by effectively
utilizing the I.T. backbone.
Enhancement of production capacity according to the future growth plans to meet
the sales growth.
External and internal assessment
Company: Jawa Pharmaceuticals pvt Ltd.
PESTLE:
9 | P a g e
PESTLE analysis stands for "Political, Economic, Social, Technological, Legal and
Environmental analysis" and help organizations making STRATEGIES by helping them to
understand the external environment in which the companies operate the functions.
PESTLE analysis of Jawa Pharmaceuticals Pvt Ltd.
Political:
When we talk about any Pharmaceuticals company in the context of PESLE analysis,
we came to know that these companies have not any direct impact of political condition.
Economical:
Economical condition has a greater influence on Pharmaceutical companies, because
in Un-stable economical condition like Inflection or recession situation the company has to
change its strategies. The strategies align according to the Economical situation of country.
Social:
Social condition also have its direct impact on Jawa Pharmaceuticals, like in the situation of
War all the foreign companies will shut down there operations and it’s time for the locals
companies to support their nation. As the other firms shut off the production of the local
companies would increase to meet the requirement of consumers.
Technology:
It is also an important factor that influence on JAWA pharmaceuticals, because now
a days there is a rapid growth in the technology a lot of innovations and advancement is
10 | P a g e
there in the machineries that enhance the firm`s production, reduce time and give better
quality, so to compete with other firms you also have to better your system.
Legal:
The government and the legal authorities has greater impact on the pharma
industry. The more important factor that has a greater influence on Pharmaceuticals
companies, like Quality control, environmental control authorities etc.
Environmental:
Environment has also its effects on pharmaceutical company and as well to its
product which cause increase in the products sale and on the other hand to shut off the
organization. Like: recently the flood and Dengue virus in Pakistan boosted the sale of
medicines.
MIKLEPORTER’S FIVE MODELS
Mikleporter provides a frame work that an industry is influence by these forces:
1. Rivalry:
Pharma industry is one of the most competitive industries in the country with as many
11 | P a g e
different rivals’ fights for selling the same product with different names. At this stage
the JAWA Pharmaceutical has four major competitors that are the local competitors:-
IrzaPharma
Unexo Laboratories
MunwarPharma
Drug Pharma
2. Bargaining power of Customers:
The unique feature of Pharma industry is that the end user is very important who buys the
product. The consumer has a greater choice to buy the same product from other
manufacturer. However, when we look at the buyer's power, we look at the influence they
have on the prices of the product. Government with its policies plays an important role in
regulating pricing through the NPPA (National Pharmaceutical Pricing Authority).
In the JAWA pharmaceutical the product is sold by the two ways:-
Over the Counter Sales (OTC)
Sales Representative
3.Bargaining power of Suppliers:
The Pharma industry depends upon several organic chemicals. The chemical industry is
again very competitive and fragmented. The chemicals used in the Pharma industry are
12 | P a g e
largely a commodity. Because of the economical changes in the country the prices of the
raw material is increasing very rapidly which cause the high rate of the raw materials.
The active materials are also imported from China and India which cost the company at the
competitive rates.
4.Threat of substitutes:
The biggest threat to the pharmaceutical industry is the substitute products which are been
developed by the competitors and are named differently having the same chemical
composition. Therefore the companies which enter newly in the Pharma business they
develop the products at the less prices causing the customer turn towards their products.
The substitute herbal products are causing the great threat to the JAWA Pharma, like the
cough controlling syrup made herbally by the Quershi is damaging the market share of the
JAWA cough control syrup.
5.Potential entry of new Competitors:
It is not only incumbent rivals that pose a threat to firms in an industry; the possibility that
new firms may enter the industry also affects competition. Industries possess
characteristics that protect the high profit levels of firms in the market and inhibit
additional rivals from entering the market. The new entrant should have to get the legal
orders from the Government to make any product and for registering the firm. High growth
prospects make it attractive for new players to enter in the industry. The industry
attractiveness is low.
EFE MATRIX
13 | P a g e
Opportunities Weight Rating Weighted score
1. Export 0.10 3 .30
2. Regulated Market .07 2 .14
3. Enhance product Lane .10 3 .30
4. Related diversification .08 3 .24
5. Environmental changes .07 2 .14
Threats
1. Bargaining Power of Supplier .12 3 .36
2. Bargaining power of Customer .09 3 .27
3. Customer loyalty .09 3 .27
4. High Competition .10 4 .40
5. Time issues .08 3 .24
6. License Procedures .10 3 .30
1 2.96
IFE MATRIX
14 | P a g e
Strength Weight Rating Weighted score
1. Technological Advancement .13 4 .52
2. Quality Certificates (ISO) .10 4 .40
3. Business Growth .09 3 .27
4. M.I.S. .08 3 .24
5. Research & Development .11 3 .33
Weakness
6. Centralized System .12 1 .12
7. Employee Moral .10 1 .10
8. Time Utilization .08 2 .16
9. Trained Staff .10 2 .20
10.Loyalty in Worker .08 2 .16
1 2.50
15 | P a g e
C.P.M
JawaPharm
a
IrzaPharma DrudPharma
Critical
success factor
Weight Rate Score Rate Score Rate Score
Advertising .16 2 .32 2 .32 2 .32
Customer
loyalty
.18 2 .36 2 .36 1 .18
Management .13 3 .39 3 .39 2 .26
Export .16 3 .48 2 .32 1 .16
Market share .17 3 .51 3 .51 2 .34
Product Quality .20 4 .80 3 .60 3 .60
Space matrix16 | P a g e
Internal strategic position Score External strategic position Score
Financial strength (FS) Environmental stability (ES)
1:Return on investment 3 1:Rate of inflation -3
2:Leverage 2 2:Demand Variability -4
3:Liquidty 2 3:Price range of competing
products
-2
4:working capital 6 4:Barriers to entry -1
5:Cash flow 4 5:Competitive pressure -2
6:Inventory turnover 4 6:Easy to exit -3
7:Earning per share 3 7:Price elastic of demand -2
8:Price earnings ratio 3 8:Risk involved in business -4
9: Technological changes -2
Average score 3.375 Average score -2.55
Competitive advantage (CA) Industry Strength (IS)
1:Market share -4 1:Growth potential 5
2:Product quality -3 2:profit potential 4
3:Product life cycle -3 3: Financial stability 4
4:Customer loyalty -6 4:Resource utilization 3
5:Competation capacity -4 5:Ease of entry into market 1
6:Contorl over suppliers &
distributer
-3 6:Productivity, capacity,
utilization
3
7: Technological know how -3 7: Technical know how 5
Average score -3.71 Average score 3.57
17 | P a g e
Internal factors
External factors
Strengths
Technological advancement
Quality Certificate (ISO)
Business growth M.I.S Research &
development
Weaknesses
Centralized system Lack of Loyalty in
worker. Time utilization. Lack of trained staff. Employee morale
Opportunities
Export Enhanced product
lane Related
diversification Environmental
changes
(S.O) Strategies
Updating machinery for enhancing product lane.
Certification for quality production.
(W.O) Strategies
Trained employees should be hired for export.
Loyalty in employees of enhancing product lane
Threats
Barging power of suppliers
Barging power of customer
Lack of customer loyalty
High competition Time issues Licensed
procedures
(S.T) Strategies
Business growth by using backward integration.
Quality certification for gaining customer loyalty.
Better M.I.S for solving time issues.
(W. T) Strategies
Hiring of Trained staff for increasing sales and manufacturing.
Time should be minimized for gaining licenses.
18 | P a g e
S.W.O.T
POSITION IN BOSTAN CONSULTING GROUP
(BCG) MATRIX
The position of our product in the BCG matrix can be identified on the basis of following
facts regarding our product:
Industry growth rate is very high
low market share is there for the product
Higher Market share could easily be achievable in future.
Grand Strategy Matrix19 | P a g e
Anti-anemic
Antibacterial & Analgesics Antacid & multi-vitamins
Cold, Cough & External prep.
IE matrix:
Core Competency Analysis
20 | P a g e
Rapid Market Growth
Low Market Growth
Strong Competitive Position
Weak Competitive Position
Quad-II Quad-I
Quad-III Quad-IV
The core competency of Jawa pharmaceuticals is its R & D Department which moves on
innovating and discovering the new product for the health of people. Jawa have very hard
working employees in R & D department which is considered as a backbone for the
company. Jawa does not compromise the quality on profitability and search on for the
better tomorrow. That`s why they say that we are dedicated to provide quality medicine
and having the ISO 9001:2000 certified organization we follow standard operating
procedures with a defined quality policy.
Corporate Culture:
Jawa pharmaceuticals is using the traditional corporate culture with in the management
efficiency, the strong reasons to use the traditional culture is due to practicing the
centralized decision making system. The organization is having the weak culture because
there are no shared values and beliefs. Employee works according to the values and
traditions owner. The department heads are responsible for their domain and there are
no group meetings.
Strategies under taken at:
Corporate level:
At the corporate level all the corporate level strategies are been made by the
key players of the company. Such as the organization is being using market development,
product development and related diversification.
Business level:
At the business level the heads of departments make strategies accordings to
the rules of the organization with the concent of key players and that strategies are
alligned wuth the corprate level strategies.
Fuctional level:
21 | P a g e
At the functional level the strategies are given by the departments supervisiors and
every one is responsible for their own work. The supervisior are accountable to the
management.
Management strategies
Adminstration department:
The administration department has 3 assistance it also includes the mintance head
and security persons . Due to the small firm and the weak organizational culture all the
adminstration strategies are implmented and made by the management director.
Decision Making
Jawa Pharmaceuticals is practicing Centralized Decision Making all the decisions are being
made by Chief Executive Officer Sajid Ali Jawa. The organization has a Tall Structure.
Total Quality Management
Quality Control:-
We have a modern and well-equipped Quality Control (QC) Laboratory, which ensures that
our products are pure, safe and effective. Each product must pass the requisite analysis as
per stringent compendia specifications, methods and procedures developed according to
international guidelines.
The QC department performs following activities:
RM/PM analysis
Finished Products analysis
In-process Checks
Stability Studies
Quality Assurance:-
22 | P a g e
Our QC department has all necessary instruments for analysis of API, finished products,
packaging and related materials used.
Finished products are not supplied sold before authorized personnel have cert production
batch has been produced and controlled in accordance with the requirement and
conformed to the required specification and standards.
The effectiveness of the quality management system is checked at appropriate it self
inspections and audits.
All products which are sold in the market are monitored through a comprehensive
Surveillance System. In case of any complaints from the market, proper investing out to
discover the root cause of the compliant. Appropriate preventive and correct are taken
promptly in order to prevent recurrence.
Marketing AnalysisSegment & Target Market
Marketing Segmentation
We segment our market by keep in view the different factors of market.
Target Market23 | P a g e
Geographic`s Country: PakistanDencity: Urban & ruler
Demographic`s Gender:Male & femaleAge: All ages
psychographic`s Social class: Upper, Upper middle, Middle Class and lower class
Doctors, NGOs, Govt. hospitals, Private Clinics are the main target market for Jawa
Products.
4 P’s of Market Analysis
Product:-
The product lane of Jawa Pharmaceutical is as under:-
PRODUCT LIST
ANALGESICS, ANTIPYRETIC, ANTIRHEUMATIC
SR PRODUCT NAME GENERIC NAME DOSAGE
FORM PACKING
1 Ambrofen Ibuprofen 100mg/5ml Suspension 90ml
2 Ambrofen Ibuprofen 100mg/5ml Suspension 400ml
3 Amnic Mefenamic Acid 50mg/5ml Suspension 60ml
4 Amnic Mefenamic Acid 50mg/5ml Suspension 450ml
5 Ambrofen Ibuprofen 200mg Tablets 500's
6 Ambrofen Ibuprofen 200mg Tablets 50X10's
7 Ambrofen Ibuprofen 400mg Tablets 250's
8 Ambrofen Ibuprofen 400mg Tablets 25X10's
9 Amnic Mefenamic Acid250mg Tablets 1000's
10 Amnic Mefenamic Acid250mg Tablets 60X10's
11 Paracetamol Paracetamol 500mg Tablets 1000's
12 Paracetamol Paracetamol 500mg Tablets 20X10's
13 Aspirin Aspirin300mg Tablets 1000's
24 | P a g e
14 Jfenac Diclofenac Sodium 50mg Tablets 2X10's
15 Jfenac-P Diclofenac Potassium 50mg Tablets 2X10's
16 Zebroxen Neproxen Sodium 275mg Tablets 3X10's
17 Zebroxen Neproxen Sodium 550mg Tablets 2X10's
18 Taprofen Flurbiprofen100mg Tablets 3X10's
19 Jcenac Aceclofenac100mg Tablets 1X10's
20 Joxicam Meloxicam 7.5mg Tablets 1X10's
21 Joxicam Meloxicam 15mg Tablets 1X10's
22 Paincure Paracetamol 450mg + Orphanedrine Citrate 35mg Tablets 10X10's
23 Paincure Fort Paracetamol 650mg + Orphanedrine Citrate 50mg Tablets 1X10's
ANTIHISTAMINES
1 Chlorphenramine Maleate ChlorphenramineMeleate 2mg/5ml Syrup 60ml
2 Chlorphenramine Maleate ChlorphenramineMeleate 2mg/5ml Syrup 120ml
3 Chlorphenramine Maleate ChlorphenramineMeleate 2mg/5ml Syrup 450ml
4 ChlorphenramineMaleate ChlorphenramineMeleate 4mg Tablets 1000's
5 Chlorphenramine Maleate ChlorphenramineMeleate 4mg Tablets 2X50's
6 Fanoxin Fexofenadine HCl 60mg Tablets 1X10's
7 Fanoxin Fexofenadine HCl 120mg Tablets 1X10's
8 Rinex Desloratadine 5mg Tablets 1X10's
9 M.Brozine Promethazine HCl 5mg/5ml Elixir 120ml
10 M.Brozine Promethazine HCl 5mg/5ml Elixir 450ml
11 M.Brozine Promethazine HCl 10mg Tablets 1000's
25 | P a g e
12 Lortab Loratadine 10mg Tablets 1X10's
13 Lortab Loratadine 5mg/5ml Syrup 30ml
14 Lortab Loratadine 5mg/5ml Syrup 60ml
15 Jastine Ebastine10mg Tablets 1X10's
16 Cetzi Cetirizine Dihydrochloride 10mg Tablets 1X10's
17 Cetzi Cetirizine Dihydrochloride 5mg/5ml Syrup 60ml
18 Lecetzi Levocetirizine 5mg Tablets 1X10's
19 Fenoxin-CF Fexofenadine HCl 60mg, Pseudoephedrine HCl 120 Tablets 1X10's
ANTIBACTERIAL AND AMOEBICIDES
1 Amtril Trimethoprim 40mg, Sulphamethoxazole
200mg/5ml Suspension 50ml
2 Amtril Trimethoprim 40mg,
Sulphamethoxazole200mg/5ml Suspension 400ml
3 Amtril Trimethoprim 80mg, Sulphamethoxazole 400mg Tablets 200's
4 Amtril Trimethoprim 80mg, Sulphamethoxazole 400mg Tablets 20X10's
5 Amtril DS Trimethoprim 160mg, Sulphamethoxazole 800mg Tablets 100's
6 Amtril DS Trimethoprim 160mg, Sulphamethoxazole 800mg Tablets 10X10's
7 Metzol Metronidazole 200mg Tablets 20X10's
8 Metzol Metronidazole 400mg Tablets 2X10's
9 Metzol Metronidazole 400mg Tablets 10X10's
10 Metzol Metronidazole Benzoate eq. to Metronidazole Suspension 60ml
26 | P a g e
200mg/5ml
11 Mntazole Metronidazole 200mg, Diloxanide 250mg Tablets 3X10's
12 Mntazole - DS Metronidazole 400mg, Diloxanide 500mg Tablets 5X3's
13 Mntazole DiloxanideFurote
250mg ,Metronidazole(Benzoate) 200mg/5ml Suspension 60ml
14 Jawaflox Ciprofloxacin (HCl) 250mg Tablets 1X10's
15 Jawaflox Ciprofloxacin (HCl) 500mg Tablets 1X10's
16 Joxacin Ofloxacin 200mg Tablets 1X10's
17 Jevelexin Levofloxacin 250mg Tablets 1X10's
18 Jevelexin Levofloxacin 500mg Tablets 1X10's
19 Jnor Norfloxacin 400mg Tablets 2X7's
20 Jawaclar Clarithromycin 250mg Tablets 1X10's
21 Jawaclar Clarithromycin 500mg Tablets 1X10's
22 P-Lock PefloxacinMesylate 400mg Tablets 1X10's
23 J-Rox Roxithromycin 150mg Tablets 1X10's
24 Typdex Nalidixic Acid 500mg Tablets 3X10's
25 Xyrox Erythromycin Stearate eq.to Erythromycin 250mg Tablets 10's
26 Xyrox Erythromycin Stearate eq.to Erythromycin 500mg Tablets 10's
27 Mox-Q Moxifloxacin 400mg Tablets 1X5's
28 Bactocare Azithromycin Dihydrate 200mg/5ml Suspension 15ml
29 Bactocare Azithromycin Dihydrate 250mg Capsules 1X10's
30 Jawaclar Clarithromycin 125mg/5ml Suspension 60ml
31 Jalidix Nalidixic Acid 250mg/5ml Suspension 60ml
27 | P a g e
32 Xyrox Erthromycin Ethyl Succinte 200mg/5ml Suspension 60ml
33 Darphin Cephradine (as Monohydrate) 250mg Capsules 1X12's
34 Darphin Cephradine (as Monohydrate) 500mg Capsule 1x12's
35 Darphin Cephradine (as Monohydrate) 125mg Suspension 60ml
36 Darphin Cephradine (as Monohydrate) 250mg Suspension 60ml
37 Zixim Cefixime (as Trihydrate) 100mg Suspension 30ml
38 Zixim Cefixime (as Trihydrate) 400mg Capsule 1x5's
39 Zclor Cefaclor (As monohydrate) 125mg Suspension 60ml
40 Zclor Cefaclor (As monohydrate) 250mg Suspension 60ml
41 Xeclor Cefaclor (As monohydrate) 250mg Capsule 1x12's
42 Jafotax Cefotaxime 250mg Injection 1 Vial
43 Jafotax Cefotaxime 1gm Injection 1 Vial
44 Darphin Cepharadine 500mg Injection 1 Vial
45 Fopera Cefoperazone 1gm, Sulbactum 1gm Injection 1 Vial
46 Fopera Cefoperazone 0.5gm, Sulbactum 0.5gm Injection 1 Vial
47 T-Zd Ceftazidime 250mg Injection 1 Vial
48 T-Zd Ceftazidime 1gm Injection 1 Vial
49 Jewpime Cefepime 500mg, Sterile Arginine 250mg Injection 1 Vial
50 Jewpime Cefepime 1gm, Sterile Arginine 500mg Injection 1 Vial
51 Try-x Ceftriaxone 250mg Injection 1 Vial
52 Try-x Ceftriaxone 1gm Injection 1 Vial
ANTACID, ANTIFLATULENTS & ANTIULCER
28 | P a g e
1 Carminative Mixture
“Sod. Bicarbonate 5g, SpiritammoniaAromat 6.5ml,
Tr. Cardco 6.5ml, Aqua Mentha Pip Conc.
4.8ml/100ml"
Mixture 120ml
2 Carminative Mixture
“Sod. Bicarbonate 5g, SpiritammoniaAromat 6.5ml,
Tr. Cardco 6.5ml, Aqua Mentha Pip Conc.
4.8ml/100ml"
Mixture 450ml
3 Mebrosil Mag. Trisilicate 500mg, Aluminium Hydroxide
250mg Tablets 500's
4 Mebrosil Mag. Trisilicate 500mg, Aluminium Hydroxide
250mg Tablets 50x10's
5 Soda Mint Sodium Bicorbonate 300mg Tablets 1000's
6 Amtri Mag. Trisilicate 500mg Tablets 1000's
7 Amtri Mag. Trisilicate 500mg Tablets 50x10's
8 Rantab Ranitidine 150mg Tablets 1x10's
9 Stomachcare Famotidine 20mg Tablets 2x10's
10 Stomachcare Famotidine 40mg Tablets 1x10's
11 Stomachcare Famotidine 10mg/5ml Suspension 60ml
12 Pentazole Pantoprazole 40mg Tablets 14's
13 R-bzole Rabeprazole Sodium 10mg Tablets 1x10's
14 R-bzole Rabeprazole Sodium 20mg Tablets 1x14's
15 Mebrazole Omeprazole 20mg Capsules 2x7's
16 Laprole Lansoprazole 30mg Capsules 2x7's
29 | P a g e
17 Ulcicare Esomeprazole 20mg Capsules 2x7's
18 Ulcicare Esomeprazole 40mg Capsules 2x7's
ANTI-ANAEMIC PREPARATIONS
1 Ferrous Sulphate Ferrous Sulphate 200mg/5ml Syrup 120ml
2 Ferrous Gluconate Ferrous Gluconate 300mg/5ml Syrup 120ml
3 Fertogen Iron Polymaltose Complex eq. to Elemental Iron
50mg/5ml Syrup 60ml
4 Fertogen Iron Polymaltose Complex eq. to Elemental Iron
100mg Tablets 1x10's
5 Fertogen-F Iron Polymaltose Complex eq. to
Elemental Iron 100mg+Folic Acid 0.35mg Tablets 1x10's
6 Hemo-GB Iron Proteinsuccinylate 800mg, Elemental Iron
40mg/15ml Syrup 60ml
ANTHELMINTICS
1 Piperazine Piperazine Citrate eq. to Piprazine Hydrate 750mg Elixir 30ml
2 Piperazine Piperazine Citrate eq. to Piprazine Hydrate 750mg Elixir 450ml
3 Jenzole Albendazole 200mg/5ml Suspension 10ml
4 Jenzole Albendazole 200mg Tablets 2's
5 Jenzole Albendazole 200mg Tablets 1x10's
6 Zenzol Mebendazole 100mg Tablets 6x10
7 Zenzol Mebendazole 100mg/5ml Suspension 30ml
ANTIMALARIALS
1 Chloroquine Phosphate Chloroquine Phosphate eq. to Chloroquine Base Syrup 60ml
30 | P a g e
50mg/5ml
2 Chloroquine Phosphate Chloroquine Phosphate eq. To Chloroquine Base
50mg/5ml Syrup 4500ml
3 Chloroquine Phosphate Chloroquine Phosphate 80mg Tablets 1000's
4 Amfan Lumefantrine 120mg, Artemether 20mg Tablets 1x16's
5 Haptoval Sulfadoxine 500mg, Pyrimethamine 25mg Tablets 1x10's
6 Zydar Sulfadoxine 500mg, Pyrimethamine 25mg Syrup 15ml
BRONCHODILATORS
1 Theophylline Theophylline Sod. Glycinate 150mg Syrup 60ml
2 Theophylline Theophylline Sod. Glycinate 150mg Syrup 450ml
3 Aminophylline Aminophylline 100mg Tablets 1000's
4 Astamol Salbutamol 2mg/5ml Syrup 60ml
5 Amacure Montelukast sodium 5mg Tablets 14's
6 Amacure Montelukast sodium 10mg Tablets 14's
CARDIOVASCULAR PREPARATIONS (ANTI HYPERTENSIVE)
1 Cardiocare Amlodipine Besylate eq. to Amlodipine 5mg Tablets 2x10's
2 Cardiocare Amlodipine Besylate eq. to Amlodipine 10mg Tablets 2x10's
3 Cardat Atenolol 50mg Tablets 2x10's
4 Cardat Atenolol 100mg Tablets 2x10's
5 Jasartan Losartan Potassium 50mg Tablets 2x10's
6 Japril EnalaprilMeleate 5mg Tablets 2x10's
7 Japril EnalaprilMeleate 10mg Tablets 2x10's
COLD & COUGH PREPARATIONS
31 | P a g e
1 Amrid "Ammonium Chloride 100mg, Chlorphenramine
Maleate 2mg, Ephedrine HCl 7mg/5ml" Syrup 60ml
2 Amrid "Ammonium Chloride 100mg, Chlorphenramine
Maleate 2mg, Ephedrine HCl 7mg/5ml" Syrup 120ml
3 Amrid "Ammonium Chloride 100mg, Chlorphenramine
Maleate 2mg, Ephedrine HCl 7mg/5ml" Syrup 450ml
4 M.Brophylline “Aminophylline 32mg, Diphenhydramine 8mg,
Ammonium Chloride 30mg/5ml" Syrup 120ml
5 M.Brophylline "Aminophylline 32mg, Diphenhydramine 8mg,
Ammonium Chloride 30mg/5ml" Syrup 450ml
6 Mephen Diphenhydramine HCl 13.5mg,
Ammonium Chloride 131.5mg/5ml Syrup 120ml
7 Mephen Diphenhydramine HCl 13.5mg,
Ammonium Chloride 131.5mg/5ml Syrup 450ml
8 Ambrofen P Ibuprofen 200mg, Pseudoephedrine HCl 300mg Tablets 10x10's
9 Ambrofen-P Fort Ibuprofen 400mg, Pseudoephedrine HCl 60mg Tablets 10x10's
10 Ambrofen-P Ibuprofen 100mg, Pseudoephedrine HCl 15mg Suspension 60ml
11 Flutabs Paracetamol 500mg, PesudoephedrineHCl 60mg,
Chlorpheniramine 4mg Tablets 10x10's
EXTERNAL PREPARAION
1 Iodine Iodine 4%, Methyl Salicyclate 5% Oinment 10x25gm
2 M. Broplast “Kaolin Heavy 52.7g, Boric Acid 4.5g, Thymol Oinment 100mg
32 | P a g e
0.05g,
Methyl Salicylate 0.2ml, Peppermint Oil 0.05ml,
Glycerin 10g Propylone Glycol 32.5g/100gm"
3 Calamina Lotion Calamine 15gm, Zinc Oxide 5g/100ml Lotion 120ml
4 Tr. Benzonic Co. Benzoin 100gm, Aloe 20gm, Storex 80gm/100ml Tincture 10x25ml
5 Tr. Benzonic Co. Benzoin 100gm, Aloe 20gm, Storex 80gm/100ml Tincture 400ml
6 Tr. Iodine Mitis Iodine 2% Tincture 10x25ml
7 Tr. Iodine Mitis Iodine 2% Tincture 400ml
ELECTROLYTE
1 Amural Sod. Acid Citrate 1.25gm/5ml Syrup 120ml
2 Amural Sod. Acid Citrate 1.25gm/5ml Syrup 450ml
LAXATIVES
1 Jalac Lactoluse 67gm/100ml Syrup 120ml
MULTIVITAMINS, CALCIUM PREPARATION
1 M. Broplex Thiamine HCl 3mg, Riboflavin 3mg,
Pyridoxine 2mg, Nicotinamide 23mg/15ml Syrup 60ml
2 M. Broplex Thiamine HCl 3mg, Riboflavin 3mg,
Pyridoxine 2mg, Nicotinamide 23mg/15ml Syrup 120ml
3 M. Broplex Thiamine HCl 3mg, Riboflavin 3mg,
Pyridoxine 2mg, Nicotinamide 23mg/15ml Syrup 450ml
4 M. Broplex Thiamine HCl 1mg, Riboflavin 1mg,
Nicotinamide 15mg/tablet Tablets 1000's
5 M. Broplex Thiamine HCl 1mg, Riboflavin 1mg, Tablets 2x50's
33 | P a g e
Nicotinamide 15mg/tablet
6 Mcobal Mecobalamine 500 g Tablets 2x10's
7 Cal-P Vitamin D 350IU, Calcium Phosphate (Tribasic)
210mg/5ml Syrup 120ml
8 Calchew-D Calcium Carbonate 1250mg, Vitamin D 125IU Tablets 30’s
9 M. Brovit
"Vit. A 2500 IU, Vit. D 250 IU Ascorbic Acid 15mg
Thiamine
HCL 0.55mg, Riboflavin 0.65mg, Nicotinamide
5.5mg/5ml"
Syrup 60ml
10 M. Brovit
"Vit. A 2500 IU, Vit. D 250 IU Ascorbic Acid 15mg
Thiamine
HCL 0.55mg, Riboflavin 0.65mg, Nicotinamide
5.5mg/5ml"
Syrup 120ml
ORAL HYPOGLYCAEMICS
1 Mfor Metformin 500mg Tablets 5x10's
2 Zenzide Gliclazide 80mg Tablets 2x10's
ANTI EMETICS
1 Jperidon Domperidone 10mg Tablets 5x10's
2 Jperidon Domperidone 5mg/5ml Suspension 120ml
3 Vompride ItoprideHCl 50mg Tablets 1x10's
ANTIVIRAL
1 Virakil Ribavirin 200mg Capsule 1x10's
2 Virakil Ribavirin 400mg Capsule 1x10's
34 | P a g e
3 Virakil Ribavirin 600mg Capsule 1x10's
ANTIFUNGAL
1 Fungazole Fluconazole 150mg Capsule 1x1's
2 Atcon Itraconazole (Pellets) 100mg Capsule 1x4's
3 Canditic Fluconazole 200mg Capsule 1x4's
ANTIOBESITY
1 Livvel SibutramineHCl 10mg Capsule 1x4's
2 Livvel SibutramineHCl 15mg Capsule 1x4's
ANTIEPILEPTICS
1 G-Tin Gabapentin 100mg Capsule 1x10's
2 G-Tin Gabapentin 300mg Capsule 1x10's
3 G-Tin Gabapentin 400mg Capsule 1x10's
HYPOLIPDAEMICS
1 Cholein Atorvastatin 10mg Tablets 1x10's
2 Cholein Atorvastatin 20mg Tablets 1x10's
3 E-Zee Ezetimibe 10mg Tablets 1x10's
CHOLAGOGUES & HEPATIC
1 Liveright
L-Ornithine L-Aspartate 300mg, Nicotinamide
24mg,
Riboflavin Sodium Phosphate 0.76mg/5ml
Syrup 60ml
35 | P a g e
Pricing
Jawa is using penetration pricing strategy but are not compromising on quality.
Place
According to the placement of JawaPharmaceutical it has covered 50% share in Punjab &
NWFP, its 30% share is in Sindh and 20% share in Balochistan.
Promotion
Jawa’s marketing strategies contribute Maximum to company's growth by achieving the set
objectives keeping in view the market opportunities timely generation of revenue,
inclusion of value added products through optimal utilization of recourses.
They arrange many conferences, seminars, lectures on various diseases, broachers, diary
and souvenir to doctors.
Market Share
As there are many competitors in the Pharmaceutical industry but the direct competitors of
JawaPharma are IrzaPharma, Drug Pharma, UnexoPharma. UnexoPharma is the market leader.
JawaPharma and IrzaPharmais market challenger and have approximately equal share.
USP
The unique selling point of Jawa Pharmaceutical is to provide best quality product to their
customers at competitive price and its Vision Statement says:-
“Committed to save Humanity”
36 | P a g e
Other Strategies
Research & Development
Jawa Pharmaceutical has an established Product Development laboratory where new form
developed under supervision of high qualified and experienced technical staff. In not only new
formulations are developed but also analytical methods for new product are developed &
validated.
Our product development lab has successfully introduced formulations in therapeutic areas
such as antibiotics &anti infective, cardiovascular preparations, analgesic, NSAIDs & newer anti-
Rheumatic such as COX-2 inhibitors, antiviral, vitamins, cholesterol lowering agents, Anti-
Anemic, anti-allergic etc.
Production
The production department has always been the back bone of the company and is a great
reason for the growth of the company. Jawa pharmaceuticals has divided its production
departments into 4 different sections that are
Tablet
Syrup
Injection
Capsuls
All the above mentioned products have different sections where these products are
produced, packed and designed. All the departments heads are accountable for their
demartments to the production director. Which overview the work activities. The
organization is using the batch production system.
Problem Section37 | P a g e
Main problem according to the Management:
Low employee morale and less interest in work.
Lack of customer loyalty.
High rate employee turn over.
Main problem acourding to our analysis:
Ceneteralized decision making system increases the time utalization.
HR department is not working propely and they are not having any specified job
discription for the emloyees and not having any pactulier HR activities.
Sub problems:
Company is not having the proper M.I.S system working.
Strategies Alterbatives
Solution to solve the problem:
The company sales force should activitely meet the customers twice in a week and
described their products benefits, assured quality at competative prices to them.
The management should allow the employees to participate activiely in decision
making process. It help the company to develop a friendly enviornment which leads
38 | P a g e
to generate the innovate ideas and helps in making proper strategies. The other
note able benefit is that employee feel comfort at work place that gradually makes
his/her interest in the work.
The company should developed a proper HR department that would generate a
efficient work force and also over come the companies other problems like incitives
and motivation technique, low employee morale and interest
IMPLIMENTING PLAN
We suggest the proper HR department i.e:-
HR VISIONThere should be a proper HR vision in the line of which company should hire dynamic and efficient employees which will definitelyhelps in increasing the growth of company. Proper training should be given to the employees to polish the skills and enhance their knowledge about the Pharmaceuticals industry.
TRAINING AND DEVELOPMENTCompanyshould encourage the employees to enhance their knowledge and skills base, and support their efforts through trainings. Their Training and Development program should outlines clear paths for professional development on either a technical or a managerial level. Meeting up with different people from different backgrounds during the training program gives exposure and broadens their horizons, resulting into new and innovative ideas. Company should ensure the employees to have the skills and leadership abilities to succeed and reach their full potential.
SALARYCompany should develop the best compensation packages with refers to the market.We suggest the following benefits and privileges for the motivation of employees to JAWA Pharmaceuticals.
Group Life Insurance
Provident fund Leave benefits Leave encashment Health Insurance (self & family) Medical Allowance
39 | P a g e
Bonus Annual gathering Transport facilities Hajj draws
RECRUITMENT AND SELECTIONJawa pharmaceuticals should recruit and select their employees only on the basis of merit. They should hire employees without any regard to race, color, religion, gender and marital status. Jawa pharmaceuticals should adopt the policy of hiring the right person for the right job, to ensure that they are operating maximum efficiency level.
40 | P a g e